FABP4 and lipodystrophy: Similarly, Escoté et al. [34] measured FABP4 in patients undergoing antiretroviral therapy, including prolonged stavudine treatment, and noted a significant correlation between increased FABP4 levels and the occurrence of lipodystrophy.